Literature DB >> 25830134

Chronic eosinophilic leukemia with a FIP1L1-PDGFRA rearrangement: Two case reports and a review of Korean cases.

Sang-Yong Shin1, Chul-Won Jung2, Dong-Chull Choi2, Byung-Jae Lee2, Hee-Jin Kim1, Sun-Hee Kim1.   

Abstract

Entities:  

Year:  2015        PMID： 25830134      PMCID： PMC4377343          DOI： 10.5045/br.2015.50.1.58

Source DB:  PubMed          Journal:  Blood Res        ISSN： 2287-979X


× No keyword cloud information.
  8 in total

1.  A case of chronic myelomonocytic leukemia with severe eosinophilia having t(5;12)(q31;p13) with t(1;7)(q10;p10).

Authors:  Myungshin Kim; Jihyang Lim; Ahwon Lee; Gyeongsin Park; Yonggoo Kim; Kyungja Han; Chang Suk Kang; Yoo-Jin Kim; Jeong-Sup Song
Journal:  Acta Haematol       Date:  2005       Impact factor: 2.195

2.  CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.

Authors:  Animesh Pardanani; Rhett P Ketterling; Stephanie R Brockman; Heather C Flynn; Sarah F Paternoster; Brandon M Shearer; Terra L Reeder; Chin-Yang Li; Nicholas C P Cross; Jan Cools; D Gary Gilliland; Gordon W Dewald; Ayalew Tefferi
Journal:  Blood       Date:  2003-07-03       Impact factor: 22.113

3.  8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.

Authors:  Tae Sung Park; Jaewoo Song; Jin Seok Kim; Woo Ick Yang; Sungwook Song; Sue Jung Kim; Borum Suh; Jong Rak Choi
Journal:  Cancer Genet Cytogenet       Date:  2008-03

4.  [Incidence and causes of hypereosinophilia (corrected) in the patients of a university hospital].

Authors:  Da Woon Kim; Myung Geun Shin; Hyeong Kee Yun; Soo Hyun Kim; Jong Hee Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  Korean J Lab Med       Date:  2009-06

Review 5.  Acute myeloid leukemia associated with FGFR1 abnormalities.

Authors:  Hyeyoung Lee; Myungshin Kim; Jihyang Lim; Yonggoo Kim; Kyungja Han; Byung-Sik Cho; Hee-Je Kim
Journal:  Int J Hematol       Date:  2013-04-23       Impact factor: 2.490

Review 6.  Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.

Authors:  J Gotlib; J Cools
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

7.  Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

Authors:  Princess U Ogbogu; Bruce S Bochner; Joseph H Butterfield; Gerald J Gleich; Johannes Huss-Marp; Jean Emmanuel Kahn; Kristin M Leiferman; Thomas B Nutman; Florian Pfab; Johannes Ring; Marc E Rothenberg; Florence Roufosse; Marie-Helene Sajous; Javed Sheikh; Dagmar Simon; Hans-Uwe Simon; Miguel L Stein; Andrew Wardlaw; Peter F Weller; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

8.  A case of idiopathic hypereosinophilic syndrome presenting with acute respiratory distress syndrome.

Authors:  Kyung-Suk Lim; Jaehoon Ko; Seong Soo Lee; Beomsu Shin; Dong-Chull Choi; Byung-Jae Lee
Journal:  Allergy Asthma Immunol Res       Date:  2013-09-27       Impact factor: 5.764
  8 in total
  2 in total

1.  Chronic eosinophilic leukemia with FIP1L1-PDGFRA rearrangement.

Authors:  Tae Hee Kim; Hyun Jung Gu; Woo-In Lee; Juhie Lee; Hwi-Joong Yoon; Tae Sung Park
Journal:  Blood Res       Date:  2016-09-23

2.  Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib.

Authors:  Dae Sik Kim; Sunki Lee; Chul Won Choi
Journal:  Korean J Intern Med       Date:  2017-06-28       Impact factor: 2.884
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.